Back to Search
Start Over
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma
- Publication Year :
- 2017
- Subjects :
- 10177 Dermatology Clinic
610 Medicine & health
2730 Oncology
1306 Cancer Research
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od.......885..6718e3b2c8dac8b2b1a20c9d659cbe81